Australia Animal Health Market: Industry Trends, Share 2025-2033

Australia Animal Health Market Overview

Market Size in 2024: USD 779.8 Million

Market Size in 2033: USD 1,001.6 Million

Market Growth Rate 2025-2033: 2.80%

According to IMARC Group's latest research publication, "Australia Animal Health Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The Australia animal health market size reached USD 779.8 Million in 2024. Looking forward, IMARC Group projects the market to reach USD 1,001.6 Million by 2033, exhibiting a growth rate (CAGR) of 2.80% during 2025-2033.

How Pet Ownership and Regulatory Innovation are Reshaping the Future of Australia Animal Health Market

• Driving Pet Healthcare Evolution: Australia's veterinary market is experiencing exceptional growth driven by increasing pet ownership with approximately 28.7 million pets nationwide, while advances in veterinary medicine and technology including digital imaging and AI-assisted diagnostics are transforming animal care standards.

• Powering Pharmaceutical Leadership: Pharmaceuticals dominate the market with a 57.0% share in 2024, driven by consistent advancements in veterinary drugs including anti-inflammatory treatments, while specialized pharmaceutical treatments are becoming more accessible to pet owners across urban and rural areas.

• Enhancing Animal Welfare Standards: The Australian Government works with states and territories to develop nationally consistent standards and guidelines for farm animal welfare, with Australian Animal Welfare Standards replacing Model Code of Practice to ensure livestock receive appropriate care standards.

• Attracting Innovation Investment: In January 2024, Ceva Santé Animale acquired Scout Bio to drive innovation in pet therapeutics, while major companies including Zoetis Inc, Vetoquinol SA, Elanco, Merck Co. Inc., and Boehringer Ingelheim operate as market leaders.

• Strengthening Regulatory Framework: The Australian Pesticides and Veterinary Medicines Authority (APVMA) regulates agricultural and veterinary chemical products, ensuring stockfeed and petfood products meet specified requirements for ingredients, manufacturing, labelling, and claims to maintain safety standards.

Grab a sample PDF of this report: https://www.imarcgroup.com/australia-animal-health-market/requestsample

Australia Animal Health Market Trends & Drivers:

Australia's animal health market is experiencing sustained growth driven by unprecedented levels of pet ownership and evolving attitudes toward animal care. The veterinary market demonstrates exceptional expansion potential with approximately 28.7 million pets nationwide, reflecting a cultural shift where pet owners increasingly treat their animals as family members and seek higher-quality veterinary care. This trend drives demand for specialized pharmaceutical products, advanced diagnostic services, and preventive healthcare solutions that mirror human medical advances. The increasing humanization of pets is creating market opportunities for premium products and services, while advances in veterinary medicine including digital imaging and AI-assisted diagnostics are transforming care standards across companion animal practices throughout Australia.

Pharmaceutical products represent the dominant segment of Australia's animal health market, capturing 57.0% of market share in 2024 through consistent advancements in veterinary drug development. The pharmaceutical sector benefits from ongoing innovation in anti-inflammatory drugs, antimicrobials, vaccines, and specialized therapeutic treatments that address diverse animal health conditions. Livestock pharmaceuticals have experienced significant growth due to increasing focus on food safety and animal welfare, while companion animal pharmaceuticals benefit from pet owners' willingness to invest in advanced treatments. The growing demand for specialized pharmaceutical treatments is becoming more accessible to pet owners across urban and rural areas, supported by improved distribution networks and veterinary expertise that enable complex treatment protocols previously available only in specialized facilities.

Regulatory frameworks and animal welfare standards are creating structured market growth opportunities while ensuring safety and efficacy across all animal health products. The Australian Government collaborates with states and territories to develop nationally consistent standards and guidelines for farm animal welfare, with Australian Animal Welfare Standards updating and replacing traditional Model Code of Practice requirements. The Australian Pesticides and Veterinary Medicines Authority (APVMA) serves as the primary regulator for agricultural and veterinary chemical products, ensuring that stockfeed and petfood products meet specified requirements for ingredients, manufacturing, labeling, and claims. This regulatory clarity provides market confidence while driving innovation in product development, with companies like Ceva Santé Animale making strategic acquisitions such as Scout Bio in January 2024 to advance pet therapeutic capabilities and maintain competitive positioning in this regulated environment.

Australia Animal Health Market Industry Segmentation:

The report has segmented the market into the following categories:

Product Type Insights:

• Pharmaceuticals

• Vaccines

• Feed Additives

• Diagnostics

• Medical Devices

• Others

Animal Type Insights:

• Companion Animals

• Livestock Animals

• Aquaculture

• Others

Distribution Channel Insights:

• Veterinary Hospitals & Clinics

• Pharmacies & Drug Stores

• Online Retail

• Animal Production

• Others

End User Insights:

• Veterinarians

• Livestock Producers

• Pet Owners

• Research Institutions

• Others

Application Insights:

• Treatment

• Prevention

• Nutrition

• Reproduction

• Others

Route of Administration Insights:

• Oral

• Injectable

• Topical

• Others

Breakup by State:

• New South Wales

• Victoria

• Queensland

• Western Australia

• South Australia

• Tasmania

• Northern Territory

• Australian Capital Territory

Recent News and Developments in Australia Animal Health Market

• January 2024: Ceva Santé Animale acquired Scout Bio with the aim of driving innovation in pet therapeutics, demonstrating the industry's focus on advancing specialized treatment options for companion animals while strengthening the competitive landscape through strategic partnerships and acquisitions.

• June 2024: The Animal Welfare Task Group noted updates on national standards development framework following targeted stakeholder engagement sessions, highlighting ongoing efforts to incorporate industry feedback into comprehensive animal welfare guidelines that support market growth and regulatory compliance.

• December 2024: Market analysis confirmed that pharmaceuticals dominate Australia's animal health market with 57.0% share in 2024, driven by consistent advancements in veterinary drugs and increasing accessibility of specialized pharmaceutical treatments for both companion animals and livestock across the country.

• January 2025: Research highlighted that Australia's veterinary market growth is supported by approximately 28.7 million pets nationwide and advances in veterinary medicine including digital imaging and AI-assisted diagnostics, creating unprecedented opportunities for animal health product innovation and market expansion.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales[@]imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302